Multicenter Quality Control of Hepatitis C Virus Protease Inhibitor Resistance Genotyping

Hepatitis C virus (HCV) protease inhibitor resistance-associated substitutions are selected during triple-therapy breakthrough. This multicenter quality control study evaluated the expertise of 23 French laboratories in HCV protease inhibitor resistance genotyping. A panel of 12 well-defined blinded...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Vallet, Sophie, Larrat, Sylvie, Laperche, Syria, Le Guillou-Guillemette, Hélène, Legrand-Abravanel, Florence, Bouchardeau, Françoise, Pivert, Adeline, Henquell, Cécile, Mirand, Audrey, André-Garnier, Elisabeth, Giordanengo, Valérie, Lagathu, Gisèle, Thibault, Vincent, Scholtes, Caroline, Schvoerer, Evelyne, Gaudy-Graffin, Catherine, Maylin, Sarah, Trimoulet, Pascale, Brochot, Etienne, Hantz, Sébastien, Gozlan, Joël, Roque-Afonso, Anne-Marie, Soussan, Patrick, Plantier, Jean-Christophe, Charpentier, Charlotte, Chevaliez, Stéphane, Colson, Philippe, Mackiewicz, Vincent, Aguilera, Lina, Rosec, Sylvain, Gouriou, Stéphanie, Magnat, Nelly, Lunel-Fabiani, Françoise, Izopet, Jacques, Morand, Patrice, Payan, Christopher, Pawlotsky, Jean-Michel
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society for Microbiology 2013
Konular:
Virology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3647889/
https://ncbi.nlm.nih.gov/pubmed/23426922
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JCM.03032-12
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller